 |
 |

Whole-Body Imaging for Cancer Staging
 |
 |
| Since this article does not have an abstract, we have provided the first 124 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Antoch and colleagues1 reported that combined whole-body positron emission tomography and computed tomography (PET/CT) had greater diagnostic accuracy for cancer staging than did whole-body magnetic resonance imaging (MRI). I believe, however, that the authors' use of the term whole body is misleading, as their axial scanning range for both PET/CT and MRI did not appear to examine the brain, skull, or lower extremities. Lung cancer, for instance, commonly metastasizes to the brain. Furthermore, contrast-enhanced MRI has been reported to have higher sensitivity and specificity for brain metastases than PET.2 Although true whole-body PET requires additional time for image acquisition, it may provide a more accurate staging.
Financial Disclosure: Dr Osman has received honoraria from Petnet Pharmaceuticals and Shared Medical Services.
Medhat M. Osman , MD, ScM, PhD
Department of Internal Medicine Saint Louis University Saint Louis, Mo
1. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290:3199-3206.
FREE FULL TEXT
2. Rohern EM, Provenzale JM, Barboriak DP, et al. Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology. 2003;226:181-187.
FREE FULL TEXT
Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.
JAMA. 2004;291:1320.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Whole-Body Imaging for Cancer StagingReply
Gerald Antoch and Stefan G. Ruehm
JAMA. 2004;291(11):1320.
EXTRACT
| FULL TEXT
Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology
Gerald Antoch, Florian M. Vogt, Lutz S. Freudenberg, Fridun Nazaradeh, Susanne C. Goehde, Jörg Barkhausen, Gerlinde Dahmen, Andreas Bockisch, Jörg F. Debatin, and Stefan G. Ruehm
JAMA. 2003;290(24):3199-3206.
ABSTRACT
| FULL TEXT
|